So to get it approved by your insurance company or another payer, you often need that criteria
mito-TEMPO nitroxide radical concentration was obtained by double integration followed by Spin Count module (Bruker) and expressed as the nitroxide radical per g of protein
Our quarterly and annual operating results may fluctuate significantly, which makes it difficult for us to predict our future operating results
Sodium-glucose cotransporter-2 (SGLT2) inhibitors represent a revolutionary approach in the treatment of type 2 diabetes
and 11,197,880 These statements have not been evaluated by the Food and Drug Administration
Exclusion criteria: (1) Patients with abnormal coagulation function [limits: prothrombin time (PT) between 1014 seconds, activated partial thromboplastin time (APTT) between 2540 seconds, and fibrinogen (Fib) levels between 2.04.0 g/L] and immunodeficiency [either primary immunodeficiency (congenital or hereditary conditions leading to impaired immune responses) or secondary immunodeficiency (conditions acquired through HIV infection, chronic immunosuppressive therapy, or severe malnutrition)]